No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
No Data
MediPharm Labs Extends Closing Date of Napanee Facility Sale to Jan. 31
MediPharm Labs Brief: Selling Its Napanee Facility to Kensana Health for $5.5 Million
MediPharm Labs Corp. Brief: Announcing Departure of President and Co-Founder Keith Strachan
MediPharm Labs Corp. Brief: Net Revenue $10.3 Million in Q2 2024; Adjusted EBITDA Negative $124K
MediPharm Labs Corp. Brief: Acquiring Advanced Medical Cannabis Delivery Method Technology From Remidose Aerosols
MediPharm Labs Q1 Gross Profit, Rise